Proteomics

Dataset Information

0

Effects of FTY720 on phospho-proteome of leukemic cells


ABSTRACT: : FTY720 (Fingolimod) is an immunosuppressive drug approved by FDA for Multiple Sclerosis (MS), that has gained attention as anti-cancer drug, thanks to its ability to disrupt the binding between the onco-protein SET and the tumor- suppressor phosphatase PP2A. We investigated FTY720 induced phospho-proteomic changes on acute myeloid leukemia cell lines carrying KMT2A-transocations. The phospho-proteomic data indicated that FTY720 treatment resulted in the down-regulation of phospho-sites associated to protein serine/threonine kinase activity, chromatin organisation and transcription. The findings support the hypothesis of a feedback loop between SET, PP2A and MYC, whereby FTY720 re-activates PP2A with an overall inhibitory effect on MYC, resulting in cell cycle arrest and apoptosis.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Leukocyte

DISEASE(S): Acute Leukemia

SUBMITTER: Vinothini Rajeeve  

LAB HEAD: Pedro R. Cutillas

PROVIDER: PXD038288 | Pride | 2024-01-26

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
F008515.dat Other
F008515.mzid.gz Mzid
F008516.dat Other
F008516.mzid.gz Mzid
F008517.dat Other
Items per page:
1 - 5 of 96
altmetric image

Publications


KMT2A-rearranged (KMT2A-R) is an aggressive and chemo-refractory acute leukemia which mostly affects children. Transcriptomics-based characterization and chemical interrogation identified kinases as key drivers of survival and drug resistance in KMT2A-R leukemia. In contrast, the contribution and regulation of phosphatases is unknown. In this study we uncover the essential role and underlying mechanisms of SET, the endogenous inhibitor of Ser/Thr phosphatase PP2A, in KMT2A-R-leukemia. Investigat  ...[more]

Similar Datasets

2024-05-23 | PXD047577 | Pride
2024-03-18 | PXD045779 | Pride
2021-11-02 | PXD019646 | Pride
2023-04-17 | PXD037633 | Pride
2023-03-14 | E-MTAB-10420 | biostudies-arrayexpress
2024-04-23 | PXD043111 | Pride
2015-04-30 | E-GEOD-67298 | biostudies-arrayexpress
2021-11-18 | PXD023690 | Pride
2023-03-11 | PXD036669 | Pride
2019-09-13 | PXD011931 | Pride